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Abstract 
Background—Studies in middle aged and older (masters) athletes with atherosclerotic risk 
factors for coronary artery disease (CAD) report higher coronary artery calcium (CAC) scores 
compared with sedentary individuals. Few studies have assessed the prevalence of CAD in 
masters athletes with a low atherosclerotic risk profile. 
Methods—We assessed 152 masters athletes aged 54.4±8.5 years (70% male) and 92 controls of
similar age, sex and low Framingham 10 year CAD risk scores with an echocardiogram, exercise 
stress test, CT coronary angiogram, and cardiovascular magnetic resonance imaging (CMRI)
with late gadolinium enhancement (LGE) and a 24-hour Holter. Athletes had participated in 
endurance exercise for an average of 31±12.6 years. The majority (77%) were runners with a 
median of 13 marathon runs per athlete.  
Results—Most athletes (60%) and controls (63%) had a normal CAC score. Male athletes had a 
higher prevalence of atherosclerotic plaques of any luminal irregularity (44.3% vs 
22.2%;p=0.009) compared with sedentary males  and only male athletes VKRZHGD&$&
Agatson units (AU)  DQGDOXPLQDOVWHQRVLV Male athletes demonstrated
predominantly calcific plaques (72.7%) whereas sedentary males showed predominantly mixed 
morphology plaques (61.5%).  The number of years of training was the only independent 
variable associated with increased risk of CAC >70th percentile for age and/or luminal stenosis 
 in male athletes: OR 1.08 (95% CI 1.01-1.15);p=0.016. 15 (14%) male athletes but none 
of the controls revealed LGE on CMRI.  Of these, 7 had a pattern consistent with previous 
myocardial infarction including 3(42%) with a OXPLQDOVWHQRVLVLQWKHFRUUHVSRQGLQJ
artery. 
Conclusions—Most lifelong masters endurance athletes with a low atherosclerotic risk profile
have normal CAC scores. Male athletes are more likely to have a CAC score >300 AU or 
coronary plaques compared with sedentary males with a similar risk profile.   The significance of 
these observations is uncertain but the predominantly calcific morphology of the plaques in 
athletes indicates potentially different pathophysiological mechanisms for plaque formation in 
athletic versus sedentary men. Whereas coronary plaques are more abundant in athletes, their 
stable nature could mitigate the risk of plaque rupture and acute myocardial infarction.  
Key Words: atherosclerosis; myocardial fibrosis; arrhythmia; Masters Athletes, Endurance 
exercise, coronary calcification 
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Clinical Perspective 
What is new?  
x Although overall CAC prevalence was similar between masters athletes and health 
sedentary controls, male athletes were more likely to have very high CAC scores and
coronary plaques.  
x Among male athletes, coronary plaques were predominantly calcified whereas plaques in 
sedentary men were predominantly of mixed morphology indicating that different 
pathophysiological mechanisms may be responsible for plaque formation in athletic and 
sedentary individuals. 
x A small proportion of athletic men showed scarring consistent with myocardial infarction 
on cardiac magnetic resonance imaging compared with none of the sedentary males.
What are the clinical implications? 
x Longstanding endurance exercise may modestly increase the likelihood of developing 
calcified coronary plaques.    
x While this observation could be interpreted as a deleterious consequence of exercise, it is 
also possible that the calcified and stable nature of the plaques may mitigate the risk of 
plaque disruption and acute myocardial infarction.
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Regular exercise confers a low risk profile for atherosclerosis and is associated with a 50% 
reduction in adverse events from coronary artery disease (CAD)1,2. The amount of physical 
activity required to achieve these benefits is 150 minutes of moderate exercise per week 3,4,5,6. In 
contrast, some athletes engage in several hours of intensive training per day, exceeding the daily 
recommendations by 10-15 fold, and many regularly participate in endurance events such as 
marathon running.  
 The past 2 decades have observed an exponential rise in the number of middle aged and 
older (masters) athletes who have exercised intensely since youth and who constitute an 
increasing proportion of participants in endurance events 7. While ostensibly fit and healthy,
several studies have reported high coronary artery calcium (CAC) scores 8,9,10 and myocardial 
fibrosis11,12 in such athletes. These studies generate controversy because although exercise is 
associated with a reduction in adverse events from CAD, coronary atherosclerosis is also the 
most common cause of exercise related sudden death in master athletes 12,13,14,15,16. However, 
existing studies are limited by small sample sizes, focus on men only,8,9,10,11,12 and inclusion of 
athletes with risk factors for atherosclerosis 8,9,10,11,12. Only one of these major studies has 
demonstrated increased atherosclerosis in the athletes after adjusting for their lower Framingham 
risk scores 8, therefore further studies are essential to address the controversy17. The present 
study investigated the coronary arteries of a large cohort of masters athletic men and women
without established conventional risk factors for CAD who had engaged in several decades of 
endurance exercise. 
 by guest on M
ay 3, 2017
http://circ.ahajournals.org/
D
ow
nloaded from
 
10.1161/CIRCULATIONAHA.116.026964
5 
Methods
Subjects
Masters athletes were recruited from elite running and cycling clubs in the UK through an 
advertisement placed in a popular athletic magazine18. Athletics weekly is published in print 
form and online and is the world’s only weekly athletics magazine with a broad readership 
covering all aspects of athletics and affiliated endurance sports. Exclusion criteria included a
history of CAD, family history of premature (< 40 years) CAD, diabetes mellitus, hypertension
(BP 140/90mmHg), hypercholesterolemia (>5.18mmol/l), and active or former smokers. 
Master DWKOHWHVZHUHGHILQHGDVDJHG!\HDUVZKRUDQPLOHVRUF\FOHGPLOHVSHUZHHN
and have continued to do so for at least 10 years and had competed in a minimum of 10 
endurance events including marathons (26.2miles; 42.2km), half marathons (13.1miles; 21.1km), 
10km races, or endurance cycling races ranging from 41.1 miles to 161.5miles; 66 to 260km) 
over a 10 year period. Participants who responded to the advertisements by email or telephone 
were sent a copy of the participant information leaflet and invited to attend for preliminary 
screening tests prior to recruitment.
 Healthy controls were recruited through advertisements placed in email staff bulletins at
three large London hospitals and had age, sex and Framingham 10 year CAD risk profiles similar 
to the athletes.  Controls engaged in exercise (mainly walking, jogging or swimming) in 
accordance with the physical activity recommendations for health4,19 and were subject to 
identical exclusion criteria. Written consent was obtained from all participants and ethical 
approval was granted by the National Research Ethics Service; South West-Central Bristol 
committee.
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Preliminary Screening Tests
Between September 2013 and June 2016, 234 athletes and 202 controls completed a health 
questionnaire and underwent a physical examination, 12-lead electrocardiogram (EKG) and 
biochemical tests including a fasting blood glucose level and serum lipid profile.  
Health questionnaires inquired about demographics, cardiac symptoms, medical, 
smoking, family history of cardiac disease and exercise history. The exercise history included the 
years of competitive exercise, number of competitive endurance events, weekly average 
running/cycling distances and personal best times for marathons. Physical examination included 
measurement of height, weight, peripheral pulse and blood pressure and auscultation of the heart. 
 82 (35%) athletes and 110 (54.4%) controls were excluded due to the presence of 
established risk factors for CAD (Supplementary figure 1).  The final cohort consisted of 152 
athletes and 92 relatively sedentary healthy controls and all underwent echocardiography, 
cardiopulmonary exercise stress test, 24-hour Holter, CT coronary angiogram, and 
cardiovascular magnetic resonance (CMR) with late gadolinium enhancement (LGE).  
Transthoracic echocardiography   
Two dimensional echocardiography was performed using a Philips iE33 echocardiographic 
machine (Amsterdam, The Netherlands). Standard views were obtained to measure wall 
thickness and cavity size. Doppler measurements were performed in accordance with published 
recommendations 20.
Computerized tomographic (CT) coronary angiography (CTCA)
Computerised tomographic calcium scoring and CTCA were performed using a 64 slice 
LightSpeed VCT XTe GE scanner (GE Healthcare, Milwaukee. US). SmartScore commercial 
sortware (GE Healthcare, Milwaukee. US) was used for calcium scoring.  For CTCA,
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prospective gating was used with a commercially available protocol (SnapShot Pulse, GE 
healthcare, Milwaukee. US) and the following scanning parameters: slice acquisition 64 x 
0.625mm, smallest X-ray window, Z-coverage value of 20 mm with an increment of 20mm,
gantry rotation time of 350ms and a field of view of 25cm. Subjects with a resting heart rate > 60 
beats per minute (bpm) were given intravenous metoprolol 5-20mg to achieve a heart rate of 
<60bpm.  In addition, all subjects received two 400 mcg doses of sublingual Glycerol trinitrate.  
The coronary circulation was visualised using 90ml of Ioversol (Optiray 350mg I/ml, Covidien 
UK, Hampshire, UK) contrast (flow rate of 6ml/s) followed by 100ml of 0.9% saline. A scout 
scan was performed followed by a prospectively gated calcium score scan (gantry rotation time 
of 350ms, 120 kV and 150 mA) from the tracheal bifurcation to the diaphragm, choosing 5-7 
scan blocks (field of view, 25cm) and a prospectively gated CT coronary angiogram with tube
voltage 80-100 kV adapted to body size and a tube current ranging from 500-600mA. CTCA 
images were reconstructed with slice thickness of 0.625mm, using a medium-soft tissue 
convolution kernel. All images were transferred to an external work-station (ADW 4.5, GE 
Healthcare) for analysis. 
Coronary artery calcium(CAC) scores were plotted against published percentiles for age 
and sex matched cohorts 21.  Plaque  morphology, and degree of coronary luminal stenosis were
assessed visually as per established guidelines22,23 and independently verified by a cardiologist 
(KF) and radiologist (SD) with expertise in CTCA who were blinded to the subject’s exercise 
history.   An atherosclerotic plaque was defined as an irregularity causing any degree of luminal 
stenosis. Luminal stenoses were graded as <30%, 30-49%, 50-69% and > 70%. Significant 
coronary atherosclerosis was defined as a CAC >70th percentile and/or the presence of a plaque
DVVRFLDWHGZLWK50% luminal stenosis in a single coronary segment. 
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Cardiovascular Magnetic Resonance Scan
Cardiovascular magnetic resonance scans were performed using a 1.5T magnet (Avanto, 
Siemens Medical Solutions). Left and right ventricular function, chamber dimensions and 
volumes and myocardial mass were assessed by cine steady-state free precession sequences. Late 
gadolinium enhancement (LGE) images were obtained after the intravenous bolus injection of 
0.1mmol/Kg gadoterate meglumine (Dotarem; Guerbet, Paris, France) to identify regional 
fibrosis. Inversion times were adjusted to null normal myocardium and LGE images were phase 
swapped to exclude artefact where required.  LGE was considered to represent focal myocardial 
fibrosis. Significant LGE was reported if it was in the compacted myocardium of the LV, 
excluding right ventricular insertion point LGE, right ventricular free wall LGE and trabeculae or 
papillary muscle LGE because these are considered non-specific and less reliable to interpret.
Reporting required the agreement of 3 cardiologists with expertise in CMR (VM or SR, and JM) 
blinded to the status of the participant.
Cardiopulmonary exercise test
Cardio-pulmonary exercise testing was performed using an upright position with a COSMED 
E100w cycle ergometer (Rome, Italy) with an incremental ramp protocol of 20-25 Watts/minute. 
Subjects were encouraged to exercise to exhaustion. Continuous 12-lead EKG was performed in 
DOOVXEMHFWV0\RFDUGLDOLVFKDHPLDZDVGHILQHGDV-0.2 mV or horizontal or down sloping ST 
segment depression.  Breath-by-breath gas exchange analysis was performed using a dedicated 
COSMED Quark CPEX metabolic cart (Rome, Italy) as described previously 24.  
Twenty-Four Hour Holter Monitoring
Twenty-four hour ambulatory EKG monitoring was performed using Lifecard CF Holters
(Spacelabs Healthcare, USA). Non-sustained ventricular tachycardia was defined as 
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consecutive broad complexes faster >120ESPDQGVXSUDYHQWULFXODUWDFK\FDUGLDDVFRQVHFXWLYH
regular narrow complexes >130 bpm.25 Sinus pauses were defined as > 2.5 seconds26. 
Statistical Analysis
Data are expressed as mean ± standard deviation (SD), or n (%) as appropriate and analysed 
using SPSS, version 22, (IBM, Chicago, IL). Continuous variables were tested for normality 
using a Shapiro-Wilk test. Group differences were tested with an independent sample t-test or 
Mann-Whitney U test for normally and non-normally distributed variables respectively. The 
Fishers exact test and the chi squared test were used to assess categorical data.  Given prior 
reports of sex differences in the cardiac implications of exercise15,27,28 the cardiac CT, 
echocardiographic, and CMR data were analysed in a sex-specific manner.
Among masters athletes, univariable analyses were performed to identify variables 
associated with significant CAD (defined as a CAC score > 70th percentile or a coronary luminal 
stenosis > 50%) including age, family history of coronary artery disease in the fifth to seventh 
decade, total serum cholesterol, serum HDL, systolic blood pressure stratified by sex, and years 
of exercise. A multivariable logistic regression model was constructed retaining all variables 
associated with CAD in the univariable analyses  including an interaction variable (compound of 
age and years of training).
Results
Demographics and Exercise History
Athletes were aged 54.4±8.5 years; range 40-82 years (men=55.1±9.1 and women=53.1±7.1 
years respectively).  70% were men and 92% were white.  None of the participants reported a 
prior history of cigarette smoking. There were no significant differences between athletes and 
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controls with respect to age, ethnicity, blood pressure, serum cholesterol and Framingham 10 
year CAD risk scores or a family history  of CAD in the 5th-7th decades but controls had a higher 
body surface area compared to athletes (Table 1).  
 Athletes had participated in endurance exercise for an average of 31±12.6 years. There 
was a broad range of athletic ability ranging from recreational sports participants to previous 
national champions (n=16), world champions (n=5) and world record holders (n=2). The 
majority of athletes were runners who engaged in a combination of 10k events, half marathons 
and full marathons (77%), with a median of 13 marathon runs per athlete. Ten athletes had run > 
100 marathons. Cyclists comprised the remainder of the athlete group and competed in a median 
of 85 races each.   Mean weekly training hours among athletes was 7.7±3.5 h with a median of 7 
hours. Controls exercised for 1.9±0.5 hours per week with a median of 1.5 hours. None of the 
controls had participated in prior endurance events and none had exercised for more than 2.5 
hours of moderate exercise per week.
Cardiac structure and function
Consistent with previous studies, athletes exhibited larger cardiac dimensions compared with
controls.  The mean end-diastolic left ventricular (LV) volume on CMR was 14.6% and 14.1% 
higher in male and female athletes respectively compared with controls (p<0.0001).  Both male 
and female athletes showed a 9.9% increase in maximal LV wall thickness compared with
respective controls (p<0.0001).  There were no differences in LV ejection fraction between 
athletes and controls but athletes had a larger LV stroke volume, higher right ventricular ejection 
fraction and superior indices of LV diastolic function (Table 2).  Athletes also demonstrated 
significantly higher peak oxygen consumption compared to controls (43.3 ± 7.2 ml/min/kg v 
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29.9 ± 6.6 ml/min/kg; p< 0.0001) which translated to a predicted peak oxygen consumption of 
138 ± 20.4% v 96.5 ± 17.6% for age and size (p <0.0001). 
Coronary calcium score
The majority of athletes (52% male and 78% female) and controls (59% male and 68% female) 
had a normal coronary artery calcium score (CAC=0 Agatston units) and only 25 (16%) athletes 
and 18 (19.5%) controls had a CAC > 70th percentile. Overall there were no significant 
differences between athletes and controls with respect to the proportion with CAC = 0 or CAC >
70th percentile (Table 3).  The median CAC score for both athletes and controls was zero.  
When CAC scores were analysed with respect to absolute values, male athletes revealed a 
higher prevalence of moderate to severely elevated coronary CAC scores 300;   12 (11.3%)
male athletes had a CAC score 300 Agatston units vs none of the sedentary males, p=0.009. 
The median CAC score in male athletes ZLWKD&$&ZDVhigher than in sedentary males with 
D&$&YS  (Figure 1). No differences in CAC scores were seen between athletic 
and sedentary females (Table 3).
Coronary plaques and luminal irregularities or stenoses 
Male athletes had a higher prevalence of coronary plaques compared with sedentary males
[47(44%) v 12(22%); p.0.009].  Male athletes were also more likely to have multiple plaques 
compared with sedentary males (Figure 2 a, Table 3) and multi-vessel plaques 21.7% v 3.7%  
(p= 0.0024). Coronary plaques (calcified or non-calcified) were equally prevalent in the main left 
coronary arteries among male athletes and sedentary men, but athletes showed a more diffuse 
distribution of irregularities throughout the coronary tree that were more common in the right 
coronary artery and first diagonal branch (Figure 2b). Sedentary men with plaques had relatively
minor luminal narrowing (<30%), however, 8 (7.5%) male athletes KDGDOXPLQDOVWHQRVLV
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compared to none of the male controls (p=0.05) (Figure 2c). Male runners (n = 82) and cyclists 
(n =24) did not differ with respect to CAC > 0 (50% v 42%), CAC > 100 Agatston units (17% v 
25%), CAC > 70th SHUFHQWLOHYRUDOXPLQDOVWHQRVLVY
There were no differences in CAC or the number of plaques between female athletes and their 
relatively sedentary counterparts (Table 3). 
Coronary plaque morphology 
Overall, there were 125 plaques observed in the 106 male athletes and 54 male controls. The 
majority of plaques were calcific (80; 64%), 39 (31.2%) were of mixed morphology and 6 
(4.8%) were non-calcified. Purely calcified plaques were more common in male athletes
compared with sedentary males [72(72.7%) vs 8(30.8%); p=0.0002] whereas sedentary males
had a higher prevalence of mixed morphology plaques [16(61.5%) vs 23(23.2%); p=0.0006].  
There were no differences in plaque morphology between athletic and sedentary females (Figure 
3).
Relationship between exercise volume and significant atherosclerosis
We investigated the relationship between exercise dose and significant coronary calcification in 
males by comparing the number of males with a CAC  >70th percentile in 4 arbitrary groups: (i) 
sedentary males; (ii) males who ran < 25 miles pHUZHHNRUF\FOHGNPPLOHVSHUZHHN
(iii) males who ran 25-35 miles per week or cycled between 100-150 km per week (67-93 miles 
per week) and (iv) males who ran > 35 miles per week or cycled>150km (93 miles) per week 
and failed to find a significant relationship between exercise dose and CAC > 70th percentile (p 
=0.26).    
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Determinants of significant coronary artery disease 
Risk factors for significant CAD among male athletes in univariable analyses included age [OR 
1.058 (IC 95% 1.058-1.116); p=0.039] and years of training [1.063 (IC95% 1.017-1.110); p 
=0.006].  Multivariable analysis revealed that years of training was the only independent variable 
for significant CAD in the athletic men [OR 1.080 (IC95% 1.014-1.149); p=0.016]. 
Myocardial fibrosis 
Significant CMR LGE was observed in 15 (14.2%) male athletes compared with none of the 
male controls (p=0.004).   The distribution of fibrosis is shown in Figure 4. Seven (6.6%) male
athletes showed subendocardial LGE (consistent with myocardial infarction), 5 (4.7%) had a 
midmyocardial distribution and 3 (2.8%) had an epicardial distribution.  Of the 7 athletic males 
with evident myocardial infarction, 3 (42.8%) showed significant CAD (50% luminal stenosis) 
in the left anterior descending artery with corresponding myocardial infarction in the anterior 
wall.  However, 4 had normal coronary arteries.  There was no relationship between myocardial 
fibrosis and exercise intensity, years of training or number of competitions. Only one female 
athlete had CMR LGE compared to none of the female controls which, was subendocardial 
distribution in the presence of normal coronary arteries.  
Ten (9.4%) male athletes  showed a single burst of non-sustained ventricular tachycardia
ranging from 5-11 beats compared to none of the sedentary males.  Of these, 3 had a 
subendocardial (myocardial infarction) pattern of LGE affecting the anterior wall and all 3 
UHYHDOHGVWHQRVLVLQWKHOHIWDQWHULRUGHVFHQGLQJDUWHU\Non sustained VT was detected in 
just one female athlete who had a normal CAC, no evidence of luminal stenosis on CT coronary 
angiography or LGE on CMR.  
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Discussion 
Habitual moderate physical activity is associated with fewer cardiac events. It is assumed that the 
lower risk of CAD in physically active individuals is through the control of acquired risk factors 
for atherosclerosis.  Ultra-endurance athletes have also been reported to have a greater 
vasodilatory capacity compared to sedentary individuals29. In contrast, three previous studies 
have shown a higher burden of atherosclerosis in endurance athletes compared to 
controls8,9,10raising concerns  that prodigious amounts of exercise may actually accelerate the
coronary atherosclerotic process. These studies included athletes with established risk factors for 
CAD or could not exclude the possibility that many of them had adopted an active life style in 
middle age and had higher risk factors during most of their lives. Our study in life-long masters 
athletes without conventional risk factors for CAD and a mean Framingham risk score of 3.4% 
demonstrated that most (61%) athletes showed no evidence of CAD. Also, there were no 
significant differences between the athletes and controls with respect to the number of 
individuals with completely normal calcium scores. The number of male athletes with a CAC = 0
in this study was significantly higher than in a previous study from Germany of 108 middle age 
marathon runners of similar age but higher risk profile)8 and slightly higher than a Dutch study 
of 318 asymptomatic athletic men with a generally low risk profile where 37% were former or 
current smokers10. The percentage of male athletes with a CAC > 100 Agatston units was also 
lower in our study compared with the others 8.9% v 36.1%8 and 16.4%10 respectively. These 
observations suggest that the higher coronary calcium scores in previous studies likely reflected 
higher atherosclerotic risk profile rather than a potentially deleterious exercise effect. 
 However, compared with sedentary men of similar age and a similarly low 
atherosclerotic risk profile athletic males in this study had a higher prevalence of  high (300
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AU) CAC scores (11.3% v 0%) a greater number of atherosclerotic plaques (44.3% v 22.2%) 
including multivessel plaques and a greater proportion showed FRURQDU\OXPLQDOQDUURZLQJ
50% (7.5% v 0%).  
Possible mechanisms for increased coronary plaque burden in master athletes
The precise mechanisms for these observations in masters athletes are unknown. Endothelial 
damage from increased shear stress forces during exercise due to a hyper dynamic coronary 
circulation, mechanical bending of the coronary arteries during vigorous cardiac contraction, 
exercise induced spasm of the coronary arteries producing non-laminar flow, exercise associated 
hypertension, generation of oxidative free radicals30 and a systemic inflammatory response from 
repeated bouts of intensive exercise31 have been suggested as possible factors.   It is also 
conceivable that acutely high parathyroid hormone concentrations produced by exercise may 
accelerate coronary calcification in master athletes32. The absence of increased CAD in female 
athletes has also been reported in a recent smaller study27 and may be attributable to the 
protective effect of oestrogens or the fact that atherosclerosis in general appears in females  older 
than the female athletes assessed in this study.33,34 Female athletes were 2 years younger than 
male athletes whereas CAD generally occurs 10 years later in females compared to males.28
Differences in plaque composition between master men athletes and controls 
Although male athletes had a higher burden of coronary plaques compared with male controls, 
the morphology of these plaques was predominantly calcific. The only other study to examine 
coronary plaque morphology in marathon runners showed a high prevalence of both calcified 
and non calcified plaques among runners compared with nonrunners, however over 50% of the 
runners had at least one risk factor for atherosclerosis9. Calcified plaques are considered stable, 
less prone to rupture and associated with a lower risk of adverse coronary events including 
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mortality35,36. In contrast, mixed morphology plaques, which were more common in sedentary 
men and a previous study of runners with risk factors for CAD, are lipid rich and more 
vulnerable to fissuring and subsequent thrombosis.  These differences in plaque morphology 
suggest that the pathophysiology of arteriosclerosis in athletes may differ from relatively 
sedentary individuals.  It has previously been shown that among individuals with subclinical 
CAD (CAC > 100 Agatston units) a high degree of fitness reduces the risk of adverse cardiac 
events by 75%37 and it is possible that the higher coronary plaque burden in lifelong endurance 
athletes may be partly mitigated by the stable nature of their more calcified plaques and could 
explain the overall low risk of myocardial infarction in established marathon runners38.
Whereas it is plausible that calcific plaques in masters athletes protect from acute myocardial 
infarction due to plaque rupture, the same stable calcified plaques may cause sufficient coronary 
stenosis and demand ischaemia to produce myocardial scarring and fatal arrhythmias in some 
athletes.  Consistent with this possibility is the observation of myocardial fibrosis compatible 
with a CAD pattern and non-sustained ventricular tachycardia in 3 of 8 (37.5%) male masters  
DWKOHWHVZLWKDOXPLQDOVWHQRVLV+RZHYHUmale athletes with a CAD pattern of 
fibrosis and 7 (70%) with non-sustained VT showed normal coronary arteries suggesting  that 
non-atherosclerotic mechanisms such as coronary spasm, increased thrombogenicity,39,40
coronary embolic or myocarditis may also contribute to myocardial scarring and/or ventricular 
arrhythmias in male  athletes engaged in lifelong endurance sports.  
Relationship between exercise dose and coronary calcification
The dose-response relationship between exercise and cardiovascular health has generated 
scientific and lay interest since increasing numbers of individuals have trained for, and engaged 
in, multiple endurance events. The Copenhagen study reported a U-shaped relationship between 
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running dose and all-cause mortality.  Light and moderate joggers had lower all cause mortality 
compared to sedentary non-joggers, whereas strenuous joggers who exercised approximately
four times greater than the current recommendations for healthy physical activity exhibited 
mortality rates similar to sedentary individuals.5 This study had very few mortal events (n=2) 
among the most active participants and did not provide the precise cause of death.  A 9-year 
prospective study of over one million British women showed that women engaging in daily 
strenuous physical activity had a higher risk of CAD compared to women preforming strenuous 
physical activity 2-3 times per week. However, just over a quarter of strenuously exercising 
women were smokers compared to 14-16% of women performing less exercise which may 
provide a partial explanation for these findings 41. In contrast, the data from the Henry Ford  
exercise testing project (The Fit study) showed that middle aged individuals capable of 
exercising to very strenuous workORDGV METS  (n =1900) showed a 60% reduction in all 
cause mortality compared with the reference group exercising at a workload (10-11 METS) 
conventionally considered to be associated with maximal benefit42.  Similarly , a meta-analysis 
of population studies comprising over 650,000 men and women with a median age of 62 years 
(range 21-92 years) revealed that exercising up to 10 times above the recommended physical 
activity levels were not associated with increased mortality compared with individuals exercising 
in accordance to consistent with current recommendations43. Although our study was not 
designed to measure outcomes, we could not demonstrate a relationship between the dose of 
exercise and coronary atherosclerosis even among males who cumulatively managed mileage in 
excess of a marathon per week. We were also unable to show any relationship between exercise 
duration and intensity and myocardial fibrosis.  
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Limitations
As far as the authors are aware this is the first large study to investigate subclinical CAD in a 
large cohort of athletes of both sexes with an otherwise low risk profile for atherosclerosis. 
However, there are several inherent limitations that warrant mention. This study was not entirely 
homogenous with respect to sex and included only 30% females that may have reduced the 
power of detecting any significant differences between female athletes and respective controls.
The age range of our women also suggests that probably many were not menopausal and may 
have been protected from atherosclerosis. We cannot exclude the possibility that presumably 
healthy runners were attracted to this study because they had sensed some non-specific alteration 
in exercise level or that some athletes did not fully disclose prior historical risk factors for CAD 
such as an unhealthy diet or an unfavourable family history which might have resulted in 
engagement in high endurance exercise. Diet is a potential confounder but does not feature in 
current conventional risk stratification models such as the Framingham CAD score. Although all 
our athletes denied the use of illicit performance enhancing drugs capable of accelerating 
atherosclerosis we did not perform any laboratory investigations to exclude this possibility.   
Multiple parameters were tested and we did not adjust for multiple testing, thus our 
significant findings should be considered exploratory. Most importantly the cross sectional in 
design of the study does not allow for any definitive causation effect between exercise and CAD
or the potential downstream effects of CAD, such as myocardial fibrosis and arrhythmias. Long-
term studies reporting cardiac events are not yet available in master athletes and although our 
study revealed a higher coronary plaque burden and subclinical myocardial infarction in men
engaged in lifelong endurance athletes, our findings cannot necessarily be considered to reflect 
increased event rates in this cohort in the future. 
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Conclusion 
The majority (60%) of middle aged lifelong masters endurance athletes with a low 
atherosclerotic risk profile had no coronary artery calcium. A proportion of male athletes without 
pre-existing risk factors for CAD revealed higher CAC scores and a greater number of 
atherosclerotic coronary plaques compared with healthy but relatively sedentary counterparts.  
The precise significance of these observations is uncertain but differences in plaque morphology 
between male athletes and sedentary men indicate different pathophysiological mechanisms for 
arteriosclerosis. Whereas higher CAC scores and greater coronary plaques in athletic may be 
interpreted as a deleterious effect of exercise on the coronary arteries, the calcific and stable 
nature of the plaques among athletic men may also be considered as protective against plaque 
rupture and acute myocardial infarction. Additional studies are required in larger cohorts to 
clarify the mechanisms and clinical relevance of our findings. 
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Table 1. Demographics and Arrhythmia Profile in Controls and Master Athletes.
DEMOGRAPHICS
Males Females
Controls
(±SD, range)
Athletes
(±SD, range)
P Controls
(±SD, range)
Athletes
(±SD, range)
P
54 106 38 46
Age (years) 52.5 (±8.4, 41-71) 55.1 (±9.1, 40-82) 0.08 54.2 (±9.6, 40-77) 53.1 (±7.1, 40-71) 0.54
Height (centimetres) 178.6 (±6.5, 163.5-192) 177.4 (±7.1, 151-194) 0.35 163.2 (±7.1, 145-179) 164.9 (±5.4, 154-179) 0.21
Weight (Kilograms) 83.7 (±13.0, 57.9-109) 72.9 (±8.4, 54-97) <0.0001 65.1 (±12.2, 44-99) 58.4 (±9.7, 47-103) 0.004
Body surface area (m2) 2.02 (±0.17, 1.8-2.1) 1.9 (±0.12, 1.8-2) <0.0001 1.71 (±0.18, 1.5-2) 1.62 (±0.12, 1.4-1.8) 0.005
White ethnicity n (%) 49 (91%) 99(93%) 0.54 31(82%) 44(96%) 0.07
CAD Framingham risk score (%) 4.29 (±2.96, 0.04-13.7) 4.33 (±3.3, 0.6-19) 0.9 1.74 (±1.27, 0.4-5.1) 1.32 (±0.79, 0.09-3.6) 0.08
Systolic blood pressure (mmHg) 124.2 (±7.3, 112-138) 126.8 (±9.4, 103-139) 0.1 122.7 (±10.3, 98-139) 123.0 (±11.7, 94-139) 0.9
Diastolic blood pressure (mmHg) 78.8 (±6.0, 63-94) 79.4 (±7.1, 61-99) 0.56 77.3 (±8.0, 52-91) 75.9 (±8.3, 57-89) 0.45
Total Cholesterol (mmol/L) 4.49 (±0.3, 4-5) 4.57 (±0.42, 4-5) 0.29 4.37 (±0.43, 4-5) 4.47 (±0.41, 4-5) 0.3
LDL Cholesterol (mmol/L) 2.9 (±0.3, 1.7-3.2) 2.9 (±0.4, 1.6-3.1) 0.92 2.9 (±0.3, 2.2-3.2) 2.8 (±0.3, 2.1-3.1) 0.23
Active or former smokers 0 (0%) 0 (0%) 1 0 (0%) 0 (0%) 1
Family History of CAD (age>40) 13 (24.1%) 16 (15.1%) 0.19 11 (28.9%) 10 (21.7%) 0.46
Hours exercise per week 1.9 (±0.3, 1.6-2.5) 7.5 (±3.8, 4-20) <0.0001 1.9 (±0.4, 1.5-2.5) 7.7 (±2.9, 4-15) <0.0001
Years of endurance exercise - 33.4 (±12.9, 10-47) 26.1 (±10.9, 10-30)
V02 max (ml/min/kg) 30.9 (±6.14, 22.7-42.9) 44.4 (±7.0, 26.6-64.2) <0.0001 24.5 (±5.4, 12.3-37) 40.4 (±7.3, 27.9-55.6) <0.0001
V02 max (%predicted) 95.5 (±17.0, 69-129) 132.9 (±16.2, 106-188) <0.0001 97.5 (±19.4, 51-133) 150.7 (±25.0, 106-208) <0.0001
24 HOUR EKG Males Females
Controls Athletes P Controls Athletes P
Atrial Fibrillation 0 (0%) 7 (6.6%) 0.1 0 (0%) 0 (0%) 1
Supraventricular tachycardia 2 (3.7%) 12 (11.3%) 0.14 2 (5.3%) 5 (10.9%) 0.45
NSVT 0 (0%) 10 (9.4%) 0.02 0 (0%) 1 (2.2%) 1
6LQXV3DXVHVVHFRQGV 0 (0%) 11 (10.4%) 0.02 0 (0%) 0 (0%) 1
CAD=coronary artery disease, LDL=Low density lipoprotein, NSVT=Non-sustained ventricular tachycardia
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Table 2. Cardiac Structure and Function in Controls and Masters Athletes. 
ECHOCARDIOGRAPHY
                Males            Females
Controls Athletes P Controls Athletes P
54 106 38 46
Aortic sinus (mm) 33.7 (±4.4) 33.2 (±3.6) 0.4 29.0 (±8.2) 29.6 (±3.2) 0.37
Left atrial diameter (mm) 36.0 (±4.4) 38.2 (±5.3) 0.002 32.9 (±4.8) 33.8 (±4.2) 0.31
LVIDd (mm) 48.4 (±5.0) 50.0 (±5.1) 0.047 45.1 (±4.2) 45.4 (±4.1) 0.73
IVSd (mm) 9.5 (±1.3) 10.4 (±1.4) <0.0001 8.2 (±1.2) 9.1 (±1.3) 0.001
RV outflow tract (mm) 33.0 (±3.3) 36.1 (±5.2) <0.0001 30.2 (±3.1) 31.9 (±4.1) 0.05
RV basal diameter (mm) 40.1 (±6.5)   47.1 (±6.4) <0.0001 35.1 (±7.7) 42.6 (±8.5) <0.0001
LV Ejection Fraction (%) 62.3 (±6.1) 62.0 (±7.7) 0.85 61.3 (±6.5) 65.5 (±7.5) 0.023
E/E' average 6.6 (±1.7) 6.5 (±1.6) 0.71 7.8 (±2.0) 6.2 (±1.2) 0.002
PAP (mm Hg) 18.8 (±4.2) 20.8 (±7.9) 0.35 16.5 (±4.4) 19.9 (±6.4) 0.02
TAPSE (mm) 22.3 (±3.6) 26.2 (±5.0) <0.0001 22.9 (±3.5) 26.0 (±4.7) 0.001
CARDIOVASCULAR MRI
Males Females
Controls Athletes P Controls Athletes P
LV end diastolic volume (ml) 145.7 (±28.6) 166.9 (±30.2) <0.0001 115.2 (±14.6) 131.4 (±19.2) <0.0001
Stroke volume (ml) 97.5 (±20.3) 110.1 (±20.3) 0.001 79.0 (±9.0) 92.3 (±3.2) <0.0001
LV Ejection Fraction (%) 67.5 (±5.4) 66.4 (±5.7) 0.31 68.6 (±4.2) 70.6 (±4.9) 0.06
Cardiac Mass (g) 133 (±27.6) 161.7 (±27.2) <0.0001 100.5 (±20.4) 110.02 (±18.5) 0.034
RV Ejection Fraction (%) 65.3 (±1.7) 72.4 (±6.5) 0.029 63 (±3.5) 75.9 (±5.6) <0.0001
Left atrial area (cm2) 22.2 (±4.7) 26.9 (±4.4) <0.0001 19.4 (±4.3) 24.7 (±3.5) <0.0001
Right atrial area (cm2) 23.8 (±5.7) 29.5 (±5.7) <0.0001 19.0 (±3.7) 23.8 (±4.9) <0.0001
Fibrosis (LGE) 0 (0%) 15 (14.2%) 0.004 0 (0%) 1 (2.2%) 1
EDV= End diastolic volume, IVSd=interventricular septal thickness in diastole, LGE = Late Gadolinium 
Enhancement, LV = left ventricular, LVIDd = Left ventricular internal diameter end diastole, MRI = magnetic 
resonance imaging, PAP = pulmonary artery pressure, RV = right ventricular 
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Table 3. Coronary artery calcium score and CT coronary angiography results in masters athletes and 
controls 
Parameter
Males Females
Controls Athletes P Controls Athletes P
54 106 38 46
Overall median CAC score 0 0 1 0 0 1
Median CAC score in individuals with 
coronary calcium 3 86 0.02 7 7 0.67
>50th percentile 12 (22.2%) 29 (27.4%) 0.57 12 (31.6%) 10 (21.7%) 0.53
>70th percentile 8 (14.8%) 16 (15.1%) 0.5 10 (26.4%) 9 (19.6%) 0.79
CAC>0 Agatston Units 22 (40.7%) 51 (48.1%) 0.4 12 (31.6%) 10 (21.7%) 0.33
CAC>10 Agatston units 10 (18.5%) 44 (41.5%) 0.0045 8 (21%) 5 (10.9%) 0.24
&$&$JDWVWRQ8QLWV 4 (7.4%) 20 (18.9%) 0.06 4 (10.5%) 3 (6.5%) 0.62
CAC300 Agatston Units 0 (0%) 12 (11.3%) 0.009 2 (5.2%) 2 (4.3%) 1
CAC 400 Agatston Units 0 (0%) 8 (7.5%) 0.05 1 (2.6%) 1 (2.2%) 1
SODTXH 12 (22.2%) 47 (44.3%) 0.009 8 (21.1%) 7 (15.2%) 0.57
SODTXHV 2 (3.7%) 25 (23.6%) 0.0014 2 (5.3%) 3 (6.5%) 1
YHVVHOVwith plaques 2 (3.7%) 23 (21.7%) 0.0024 2 (5.3%) 2 (4.3%) 1
>50%  luminal stenosis 0 (0%) 8 (7.5%) 0.05 0 (0%) 0 (0%) 1
Vessel wall calcification without 
luminal stenosis
10 (19.2%) 4 (3.8%) 0.005 4 (10.5%) 3 (6.5%) 0.7
CAC = coronary artery calcium
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Figure Legends
Figure 1. Tukey Box and whisker plot of coronary calcium scores in male athletes and relatively 
VHGHQWDU\KHDOWK\PDOHVZLWK&$&$JDWVWRQXQLWV&RQWURORXWOLHUV-570, **Athlete 
outliers 723-3422 
Figure 2. Coronary plaques and luminal stenoses artery in male athletes and relatively sedentary 
healthy males  a) Number of atherosclerotic plaques observed on CT angiography in male 
athletes and relatively sedentary males,  b) Distribution of coronary plaques in athletic men (99 
coronary plaques) and relatively sedentary males (26 coronary plaques), c) Luminal stenoses in 
male athletes and sedentary males.
Figure 3. Plaque morphology in male athletes (99 coronary plaques) and relatively sedentary 
males (26 coronary plaques).
Figure 4. Myocardial fibrosis in athletes demonstrated by late gadolinium enhancement on 
CMR. a) Distribution of fibrosis, b) Sub epicardial scar in a 61 year old male athlete, c) 
subendocardial scar in a 73 year old  runner d) Basolateral mid wall fibrosis in a 52 year old 
male athlete . M=Males, F=Females
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Supplemental Publication Material 
 
Supplementary figure 1: Schematic flow diagram illustrating the recruitment of master athletes and 
controls. 
 
 
